Two Sigma Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,000
Closed -$523K 2143
2014
Q4
$523K Sell
5,000
-26,000
-84% -$2.74M ﹤0.01% 1592
2014
Q3
$3.3M Sell
31,000
-53,000
-63% -$5.5M 0.02% 633
2014
Q2
$8.79M Sell
84,000
-103,000
-55% -$10.4M 0.07% 318
2014
Q1
$18.4M Buy
187,000
+31,900
+21% +$2.96M 0.17% 139
2013
Q4
$14.2M Sell
155,100
-39,900
-20% -$3.68M 0.14% 159
2013
Q3
$16.9M Buy
195,000
+130,000
+200% +$11.7M 0.2% 105
2013
Q2
$5.58M Buy
+65,000
New +$5.52M 0.08% 226

Other funds holding JNJ

Two Sigma Advisers's JNJ Position: Q1 2026 in Review

Two Sigma Advisers sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 350,509 shares — an estimated $72.5M sold.

Two Sigma Advisers first reported a position in JNJ in Q3 2013 and held it in 49 quarters. The position peaked at $579M in Q3 2019. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Two Sigma Advisers reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 350,509 Johnson & Johnson shares in Q1 2026, an estimated $72.5M.
  • Two Sigma Advisers first reported a position in Johnson & Johnson in Q3 2013 and held it in 49 quarters.
  • Two Sigma Advisers's Johnson & Johnson position peaked at $579M in Q3 2019.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.